Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Immuno-Biological Laboratories

Request full access

Immuno-Biological Laboratories is developing, manufacturing and supplying various immunological research reagents, and customized services

JapanFounded 1982Biotech & Life Sciences

About Immuno-Biological Laboratories

IBL Japan is a leading provider of customized antibodies and ELISA kits, catering primarily to pharmaceutical companies and diagnostic product manufacturers. Operating within the biotechnology sector, the company focuses on developing and supplying high-quality antibodies and diagnostic kits that meet stringent quality control standards, including ISO 13485 certification. IBL Japan's business model revolves around both product sales and contract services, generating revenue through the sale of proprietary diagnostic kits and customized antibody solutions. The company also engages in licensing agreements for antibody drugs, aiming to discover and develop valuable biological markers for therapeutic use. By maintaining a robust R&D pipeline and collaborating with international business partners, IBL Japan ensures its offerings remain at the forefront of scientific innovation.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2007
Open positions
None listed
Dealroom signal
24.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Arts & Culture
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBT✓Debt Dec 2016 $11M — Whiz Partners —
IPO✓Exit Mar 2007 $0 — Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Immuno-Biological Laboratories website traffic

Latest recorded traffic for Immuno-Biological Laboratories is 5.1K monthly website visits, down 49% over the last three months.

Latest monthly visits5.1K 3-month web change-49%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Immuno-Biological Laboratories in its local ecosystem

Live from Dealroom

The Immuno-Biological Laboratories office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Whiz Partners
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇯🇵 Japan HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Immuno-Biological Laboratories on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Immuno-Biological Laboratories’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.